Coronavirus shutdowns have quashed nearly all other common viruses. But scientists say a rebound is coming.
Veteran virus trackers say they are chronicling something never before seen — the suppression of virtually every common respiratory and gastrointestinal virus besides the novel coronavirus. They theorize that is largely due to global shutdowns, mask-wearing and a host of other health protocols aimed at stemming the spread of the coronavirus.Source: The Washington Post
New COVID-19 Related Genes – Helpful and Harmful – Found in Massive Screen
Researchers at Yale University and the Broad Institute of MIT and Harvard screened hundreds of millions of cells exposed to the COVID-19 and MERS viruses and identified dozens of genes that both enable the viruses to replicate in cells and also those that seem to slam the door on the virus.
Can We ‘Use’ One Virus To Fight off Other Viruses?
Respiratory diseases are on the rise, and scientists are leaving no stone unturned to keep existing and emerging respiratory infections at bay. In a recent study published in The Lancet Microbe, researchers at Yale University found that prior exposure to rhinoviruses, which cause about a fifth of all common-cold infections, could prevent influenza viruses from setting up an infection in the same body.Source: The Wire (Science)
Gift from Ludwig Family Foundation Funds Urgent COVID Research by School of Medicine Scientists
The donation will fund the laboratories of at least six scientists on the Yale School of Medicine faculty, for work on vaccine development to prevent future outbreaks as well as treatments for people who are already infected.
Carefully, Yale Labs Stir to Life Across Campus
Since June 1, the start of a broad, three-phase reactivation of campus, an estimated 4,000 faculty members, graduate students, and staff representing more than 500 labs around Yale have fired up microscopes, opened fume hoods, or dusted off other essential research equipment.Source: YaleNews
New Haven Dashboard Helps Guide Worldwide Covid-19 Response
In this crisis, Veoci has also set up webinars to help responders understand Covid-19. The director of Yale’s clinical virology laboratory, Marie Louis Landry, who has contact and past experience in Wuhan and is overseeing tests here in New Haven, conducted one webinar on virology and the history of the coronavirus. School of Medicine Professor Paula Kavathas did another on how the immune system responds to Covid-19.Source: New Haven Independent
Agile Analytics & Operational Intelligence for COVID-19
The global outbreak of SARS-CoV-2 (COVID-19) has been filled with uncertainty. Who is most at risk? Which symptoms are most common? What treatments are effective? The incredibly varied presentation, from asymptomatic patients to mortality further complicates assessing the true scope of infection and drives further uncertainty in how to respond to and manage the pandemic. Rapid turnaround in research from China and other locations with some of the first cases has provided invaluable information to guide the next stage of research and treatment. However, as large-scale clinical trials are difficult to deploy rapidly, much of the next wave will rely on real-world data (RWD) and observational studies paired with basic and translational research to guide the response to and management of COVID-19.Source: Medium